Nerea Vega García
After obtaining her Degree in Human Biology (Pompeu Fabra University) in 2012, Nerea Vega improve her skills in clinical laboratory techniques at the Master Laboratory of Clinical Analysis (Pompeu Fabra University) in 2013.
After starting her doctoral research at the Laboratory of Hematology of the SJD Barcelona Children’s Hospital, included in the Group of Tumors of the Development of the Institut de Recerca Sant Joan de Déu. In 2018 s he obtained her PhD in Medicine and Translational Research (Universitat of Barcelona).
Her research, entitled "Study of the histone deacetylase (HDAC) expression profile in paediatric patients with acute leukaemia" focused on the study of the expression profile of HDAC and other corregulators in order to improve our knowledge on their role in paediatric leukaemia and identify possible biomarkers and/or therapeutic targets, especially in high-risk leukemias such as infants and MLL-rearranged.
Currently, and thanks to the experience obtained during these 7 years in the Hematology Laboratory in molecular techniques, and after attending several formations (national and international) She has participated in the implementation of NGS techniques for the molecular diagnosis of patients with paediatric acute leukaemia. Moreover, she participates in national and international scientific congresses and associations, including the European Hematology Association (EHA).
Professional network profiles
- Montaño A, Hernández-Sánchez J, Forero-Castro M, Matorra-Miguel M, Lumbreras E, Miguel C, SUSANA SANTOS RUÍZ, Ramírez-Maldonado V, Fuster JL, de Las Heras N, García-de Coca A, Sierra M, Dávila J, de la Fuente I, Olivier C, Olazabal J, Martínez J, Vega-García N, González T, Hernández-Rivas JM and Benito R Comprehensive Custom NGS Panel Validation for the Improvement of the Stratification of B-Acute Lymphoblastic Leukemia Patients. Journal of Personalized Medicine . 10(3): .
- Perello C, Català-Temprano A, Caviedes L, Vega-García N, Camós-Guijosa M, Perez-Torras S and Pastor-Anglada M FMS-like tyrosine kinase 3 (FLT3) modulates key enzymes of nucleotide metabolism implicated in cytarabine responsiveness in pediatric acute leukemia. PHARMACOLOGICAL RESEARCH . 151: 104556-104556.
- Vega-García N, Malatesta R, Estella-Aguado MC, Pérez-Jaume S, Esperanza-Cebollada E, Torrebadell-Burriel M, Català-Temprano A, Gassiot S, Berrueco R, Ruiz-Llobet A, Alonso-Saladrigues A, Mesegue Meda M, Pont-Martí S, Rives-Sola S and Camós-Guijosa M Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases. BRITISH JOURNAL OF HAEMATOLOGY . 182(4): 542-553.